See SmartVest atCHEST 2026

Booth #684 Phoenix Oct 18-21

Visit SmartVest at Booth #684 to learn about the importance of treating smart from the start in bronchiectasis care. Discover how HFCWO therapy helps improve outcomes through consistent, effective airway clearance.

For over 30 years, SmartVest has been committed to advancing patient care and empowering providers and patients alike to break the cycle of infection, inflammation, and exacerbations.

Attending CHEST 2026?

We’re gearing up for CHEST 2026 in Phoenix and would love to connect with you. Fill out this quick form if you’re interested in meeting with our team. We’ll share details on hands-on sessions, where to find SmartVest and how you can join the conversation about Airway Clearance Reassessment.


Recognize. Reassess. Recommend.

Patient symptoms can change over time. Reassessing airway clearance may help identify patients who need a different approach.

Common Reassessment Triggers:

✓ Increased sputum burden
✓  Persistent cough
✓  Recurrent infections
✓  Increased symptom frequency
✓  Reduced ACT adherence

Don’t wait for another exacerbation.

Learn more about implementing SmartVest HFCWO today
Hero-Cropped

Incorporate SmartVest Into Your Treatment Plan

SmartVest is an integral part of a comprehensive bronchiectasis management plan. This portable, high-frequency chest wall oscillation (HFCWO) therapy system helps gently squeeze and release the upper body, causing mucus to loosen, thin, and propel toward the major airways, where it’s easier to cough out. When patients can clear mucus from the lungs, they work towards improving overall respiratory function.

  • 99% of SmartVest patients report feeling better or stable with SmartVest*

  • 97% of patients would receommend SmartVest*

  • Patients average Quality of Life Assessment scores (CAAT) improved by 2.3 points*

Its ease of use at home encourages consistent therapy adherence, improving patients’ quality of life. By combining effective airway clearance with targeted treatments for inflammation and infection, SmartVest® empowers patients to better manage their bronchiectasis and achieve long-term health improvements.
*patient data on file

Prescribe SmartVest

Clinical Evidence Supports the Efficacy of SmartVest:

57%
Decrease in antibiotic use1
59%
Decrease in hospitalizations1
60%
Decrease in emergency visits1
More Clinical Evidence

Clinician Resources

Click here to get access to exclusive clinician content

Clinician Resources

Go to our clinician portal to learn more!

1-1-clinician-and-patient1

  1. Sievert C et al. Respiratory Therapy, Vol. 11 No 4, 34-38, 2016.